Page last updated: 2024-12-04

2,5-dichlorophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,5-dichlorophenol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,5-dichlorophenol : A dichlorophenol with the chloro substituents at positions 2 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID66
CHEMBL ID1565192
CHEBI ID27929
SCHEMBL ID177878
MeSH IDM0159428

Synonyms (57)

Synonym
BIDD:ER0560
ec 209-520-4
4-06-00-00942 (beilstein handbook reference)
unii-3b11g9akba
3b11g9akba ,
2,5-dichloro-phenol
nsc6296
nsc-6296
CHEBI:27929 ,
3,6-dichlorophenol
inchi=1/c6h4cl2o/c7-4-1-2-5(8)6(9)3-4/h1-3,9
phenol, 2,5-dichloro-
NCGC00091138-01
ccris 5903
brn 1907692
hsdb 4287
einecs 209-520-4
nsc 6296
583-78-8
C06602
2,5-dichlorophenol
2,5-dcp
2,5-dichlorophenol, analytical standard
2,5-dichlorophenol, 98%
NCGC00091138-02
AC-10424
D0393
BMSE000673
AKOS000120929
NCGC00091138-03
dtxsid7025003 ,
NCGC00257078-01
tox21_303053
cas-583-78-8
dtxcid705003
tox21_201889
NCGC00259438-01
STL283946
FT-0610322
dichlorophenol, 2,5-
2,5-dichlorophenol [hsdb]
SCHEMBL177878
CHEMBL1565192
W-105392
F0001-1524
mfcd00002174
2,5-dichlorophenol, purum, >=98.0% (hplc)
2,5-dichlorophenol, pestanal(r), analytical standard
phenol, 2,5-dichloro-; 2,5-dichlorophenol; nsc 6296
2,5-dichlorophenol 100 microg/ml in methanol
2,5-dichlorophenol 10 microg/ml in methanol
2,5-dichlorophenol (acd/name 4.0)
CS-W004071
Q13427538
2,5-dichlorophenol--d3
EN300-20748
Z104480932

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In such cases, the adverse neurologic consequences have been presumed to result from a direct toxic effect of this small, organic molecule."( Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity.
Cheong, R; Cortese, IC; Newman-Toker, DE; Wilson, RK, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dichlorophenolAny chlorophenol carrying chloro substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (29)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency1.12200.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency70.79460.004023.8416100.0000AID485290
Chain A, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID886
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency35.48130.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency10.00000.001318.074339.8107AID926; AID938
farnesoid X nuclear receptorHomo sapiens (human)Potency0.00400.375827.485161.6524AID588527
estrogen nuclear receptor alphaHomo sapiens (human)Potency21.87510.000229.305416,493.5996AID743069
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency56.50420.023723.228263.5986AID743222
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency17.78280.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.48560.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency22.28690.000627.21521,122.0200AID743202
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency31.62280.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.56)18.7374
1990's3 (8.33)18.2507
2000's7 (19.44)29.6817
2010's21 (58.33)24.3611
2020's3 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.27 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.56%)6.00%
Case Studies2 (5.13%)4.05%
Observational0 (0.00%)0.25%
Other36 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]